March 20 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS:
SUN PHARMA - LAUNCHES ITS SEMAGLUTIDE INJECTION UNDER BRAND NAMES, NOVELTREAT AND SEMATRINITY IN INDIA
SUN PHARMA - PHARMA LAUNCHES SEMAGLUTIDE INJECTION UNDER NOVELTREAT AND SEMATRINITY IN INDIA
SUN PHARMA - NOVELTREAT WEEKLY THERAPY COSTS 900 RUPEES-2,000 RUPEES; SEMATRINITY 750 RUPEES-1,300 RUPEES
SUN PHARMA - SEMATRINITY IS AVAILABLE IN TWO DOSE STRENGTHS - 2 MG/1.5 ML AND 4 MG/3 ML
SUN PHARMA: NOVELTREAT IS AVAILABLE IN FIVE DOSE STRENGTHS 0.25 MG/0.5 ML, 0.5 MG/0.5 ML, 1 MG/0.5 ML, 1.7 MG/0.75 ML, AND 2.4 MG/0.75 ML
Source text: ID:nBSE3g9RJQ
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com;))